Get an alert when VERITON PHARMA LIMITED files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Next accounts due

2027-09-30 (in 1y)

Last filed for 2025-12-31

Confirmation statement due

2027-02-04 (in 9mo)

Last made up 2026-01-21

Watchouts

1 item

Cash

£11M

+45.3% vs 2024

Net assets

£13M

+11.8% vs 2024

Employees

26

0% vs 2024

Profit before tax

£6M

-16.7% vs 2024

Watchouts

Facts from the Companies House register and the latest accounts — not a rating

Name history

Renamed 1 time since incorporation

  1. VERITON PHARMA LIMITED 2017-09-29 → present
  2. SPECIAL PRODUCTS LIMITED 1997-01-21 → 2017-09-29

Accounts

2-year trend · latest reflected 2025-12-31

Metric Trend 2024-12-312025-12-31
Turnover £21,520,000£19,670,000
Operating profit £7,440,000£6,316,000
Profit before tax £7,476,000£6,224,000
Net profit £5,578,000£4,733,000
Cash £7,888,000£11,462,000
Total assets less current liabilities £11,426,000£12,658,000
Net assets £11,236,000£12,562,000
Equity £11,236,000£12,562,000
Average employees 2626
Wages £1,812,000£1,705,000

Values shown as filed in the company's annual accounts. indicates the figure wasn't present under that line item in that period. About these numbers

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio Trend 2024-12-312025-12-31
Operating margin 34.6%32.1%
Net margin 25.9%24.1%
Return on capital employed 65.1%49.9%
Gearing (liabilities / total assets) 36.7%29.3%
Current ratio 2.75x3.43x
Interest cover 310.00x371.53x

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Audit & accounting basis

Accounting basis
IFRS
Reporting scope
Standalone (parent only)
Auditor
Kreston Reeves Audit LLP
Audit opinion
Unqualified (clean)
Going concern
Affirmed

“In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate. Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the Company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.”

Group structure

  1. VERITON PHARMA LIMITED · parent
    1. Special Products Limited 100% · England · Dormant
    2. Veriton Pharma FZ LLC 80% · UAE · Sales office
    3. Veriton Pharma Pty Limited 100% · NSW · Dormant

Significant events

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

4 active · 30 resigned

Name Role Appointed Born Nationality
JENKINSON, Samuel Director 2025-01-01 Oct 1976 British
PATEL, Janit Vishnuprasad Director 2025-01-01 Sep 1969 British
SAWDON, Brindley Alexander Director 2023-06-30 Sep 1988 British
WATT, Benjamin Director 2022-10-18 Feb 1975 British
Show 30 resigned officers
Name Role Appointed Resigned
DEAN, John Brian Secretary 1997-01-21 2001-07-12
DWYER, Daniel John Nominee Secretary 1997-01-21 1997-01-21
WADE, John Leonard, Mr. Secretary 2008-12-18 2010-04-30
COLLYER BRISTOW LLP Corporate Secretary 2020-05-18 2020-07-30
COLLYER BRISTOW SECRETARIES LIMITED Corporate Secretary 2020-07-30 2025-06-11
DERRINGTONS LIMITED Corporate Secretary 2010-06-24 2020-05-18
HALCO SECRETARIES LIMITED Corporate Secretary 2001-07-12 2009-02-01
AIKEN, Hannah Mary Talbot, Dr Director 2018-01-25 2020-05-18
BRAITCH, Joseph Peter Director 2005-06-01 2011-01-19
CHAN, Albert Weng Wah, Dr Director 2005-09-01 2009-06-30
CLAYDEN, Anthony Louis Director 2008-06-02 2011-10-21
DOYLE, Betty June Nominee Director 1997-01-21 1997-01-21
DRURY, Richard Director 2010-02-25 2011-03-22
DWYER, Daniel John Nominee Director 1997-01-21 1997-01-21
GRIMES, Chris James Director 2020-11-03 2022-10-31
GRIMES, Chris James Director 2014-04-24 2020-05-18
HERBERT, Kenneth Director 2011-02-01 2012-09-04
HIGHAM, Anthony Director 2023-06-30 2024-12-31
JACKSON, Robert Ward Director 2008-04-16 2010-03-31
JONES, Stephen Philip, Dr Director 2012-05-08 2020-05-18
KAUSHAL, Vinod Director 2007-12-10 2008-08-15
MADDOCK, Paul Director 2010-08-01 2013-08-08
MARCH, Carole Iris Director 2015-06-25 2020-05-18
MARCH, Graham Alan, Dr Director 1997-01-21 2020-05-18
PATEL, Janit Vishnuprasad Director 2021-02-22 2023-06-30
SAIBAN, Jason Asnam Director 2009-09-01 2020-05-18
TITTERSHILL, Andrew David Director 2013-03-01 2017-06-22
URBAIN, Jérémie Alexandre Director 2020-05-18 2021-02-22
WALLIS, Theresa Anne Director 2008-04-16 2020-05-18
WILD, Roderick William Director 2012-09-27 2020-05-18

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
Serb Ltd Corporate entity Shares 75–100%, Voting 75–100% 2025-09-11 Active
March Medical Limited Corporate entity ownership-of-shares-75-to-100-percent-as-firm, voting-rights-75-to-100-percent-as-firm 2016-04-06 Ceased 2025-09-11

Filing timeline

Last 20 of 168 total filings

Date Type Category Description
2026-05-01 AA accounts Accounts with accounts type full
2026-02-18 CS01 confirmation-statement Confirmation statement with updates PDF
2026-02-16 PSC02 persons-with-significant-control Notification of a person with significant control PDF
2026-02-16 PSC07 persons-with-significant-control Cessation of a person with significant control PDF
2025-06-24 TM02 officers Termination secretary company with name termination date PDF
2025-04-10 AA accounts Accounts with accounts type full
2025-02-03 CS01 confirmation-statement Confirmation statement with no updates PDF
2025-01-09 AP01 officers Appoint person director company with name date PDF
2025-01-09 AP01 officers Appoint person director company with name date PDF
2025-01-09 TM01 officers Termination director company with name termination date PDF
2024-08-14 AA accounts Accounts with accounts type full
2024-02-20 CS01 confirmation-statement Confirmation statement with no updates PDF
2023-07-06 AP01 officers Appoint person director company with name date PDF
2023-07-06 AP01 officers Appoint person director company with name date PDF
2023-07-06 TM01 officers Termination director company with name termination date PDF
2023-05-27 AA accounts Accounts with accounts type full
2023-01-24 CS01 confirmation-statement Confirmation statement with no updates PDF
2022-10-31 TM01 officers Termination director company with name termination date PDF
2022-10-21 CH01 officers Change person director company with change date PDF
2022-10-21 AD02 address Change sail address company with old address new address PDF

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
5

last 12 months

Capital events
0

last 24 months

Officers appointed
0

last 12 months

Officers resigned
1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Year-on-year

FY2024 → FY2025 · period ending 2025-12-31 vs 2024-12-31

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Official Companies House page